Evaluating a novel treatment for ALS with the assistance of AI
The Voutilainen Lab’s mission is to identify treatments for diseases such as ALS; a fatal neurodegenerative disease. Liam Beckett and Jaan Korpikoski, students in the lab, are both focusing their research on a novel protein, currently one of the most promising therapeutic candidates for ALS. In this webinar Liam and Jaan present on their research on novel ALS treatments and how they used Aiforia Create to develop an AI model to accelerate this investigation. This is followed by a short introduction to Aiforia by Aiforia's Application Manager, Sami Blom PhD.
Enter your details below to watch the video:
You can also book a demo with us to see Aiforia in action.